Los Angeles Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.02M Sell
279,922
-56,048
-17% -$205K ﹤0.01% 632
2025
Q1
$1.45M Buy
335,970
+11,959
+4% +$51.7K 0.01% 464
2024
Q4
$1.04M Sell
324,011
-6,280
-2% -$20.1K ﹤0.01% 607
2024
Q3
$945K Sell
330,291
-38,300
-10% -$110K ﹤0.01% 666
2024
Q2
$1.03M Sell
368,591
-131,976
-26% -$370K ﹤0.01% 643
2024
Q1
$1.42M Buy
500,567
+157,575
+46% +$448K ﹤0.01% 580
2023
Q4
$1.4M Sell
342,992
-53,030
-13% -$217K 0.01% 561
2023
Q3
$1.26M Sell
396,022
-145,952
-27% -$464K 0.01% 564
2023
Q2
$1.8M Buy
541,974
+38,651
+8% +$128K 0.01% 518
2023
Q1
$1.07M Buy
503,323
+117,075
+30% +$249K ﹤0.01% 647
2022
Q4
$1.04M Sell
386,248
-52,655
-12% -$142K 0.01% 696
2022
Q3
$1.42M Sell
438,903
-7,206
-2% -$23.3K 0.01% 591
2022
Q2
$2.18M Buy
446,109
+314,414
+239% +$1.53M 0.01% 516
2022
Q1
$1M Buy
131,695
+64,124
+95% +$489K ﹤0.01% 759
2021
Q4
$624K Buy
+67,571
New +$624K ﹤0.01% 901